Spectra Laboratories Inc., a Rockleigh-based subsidiary of German medical supply company Fresenius Medical Care AG & Co KGaA, announced today a definitive agreement to acquire the operating assets of Brooklyn, N.Y.-based Shiel Medical Laboratory Inc. Terms were not disclosed.
According to the announcement, the acquisition will expand Spectra's existing laboratory services capabilities in the metropolitan New York market and allow it to serve a broader base of health care providers and evolving health care delivery models. The transaction is expected to close in the fourth quarter, pending regulatory approval.
Spectra, which provides clinical laboratory services for kidney dialysis, signed a 15-year lease at its Rockleigh location in May.